MAE-WEST SCORE Leadership Administrative Core

MAE-WEST SCORE 领导力行政核心

基本信息

  • 批准号:
    10450756
  • 负责人:
  • 金额:
    $ 22.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Project Abstract – MAE-WEST SCORE LAC Over the course of life, chronic stressors contribute to multi-organ aging and dysfunction and, ultimately, the development of clinical disease. Sex remains a critical determinant of the nature and pace of aging and ultimately longevity. Among mammalian species, it is even more clear that females fundamentally age differently from males. With advancing chronologic age in humans, differences in biological aging between women and men become even more pronounced, culminating in the female predominance for a number of important morbid disease conditions, including notably Alzheimer’s disease and related dementias (ADRD), heart failure with preserved ejection fraction (HFpEF), progressive chronic kidney disease (CKD), and in turn systemic frailty. Mechanisms underlying the female predominance for these major morbidities remains unknown and are not explained by variations in sex hormones or survival bias. Our preliminary work supports a central hypothesis that sexual dimorphism in inflammatory eicosanoid mediators contribute to sex differences in microvascular dysfunction and, in turn, to sex differences in age-related multi-organ disease, including for ADRD, HFpEF and CKD. Elucidating a common pathophysiologic basis for the female predominance of ADRD, HFpEF, and CKD holds the key to effective interventions for reducing the excess burden of age-related disease in women. Motivated our findings and the critical need to understand the determinants and drivers of sex differences in major age-related disease outcomes, we propose to establish the Microvascular Aging and Eicosanoids – Women’s Evaluation of Systemic aging Tenacity (MAE-WEST) (“You are never too old to become younger!”) Specialized Center of Research Excellence (SCORE) on Sex Differences, in response to NIH RFA-OD-19-013. Our goal is to form a robust and sustainable structure of academic activities centered on systematically interrogating sex differences in the relationship among eicosanoids, microvascular dysfunction, and age-related end-organ disease, with an initial focus on the microvascular aging effects on brain, heart, and kidney function. This goal will be achieved by an outstanding collaborative team of clinician-scientists (with expertise in geriatrics, cardiology, and nephrology), epidemiologists, basic and translational scientists, analytical chemists, biostatisticians, and bioinformaticians. Leveraging our collective experience, resources, and infrastructure, we will advance the scientific enterprise through 3 foundational projects aligned and complementary yet independent. To realize the full potential of this ambitious scientific and educational agenda, we have established a Leadership Administrative Core, for overseeing operations, fiduciary responsibility, and enabling efficiency. In establishing the MAE-WEST SCORE, we will extend from existing collaborations and formalize an organization of scientific and mentoring leadership that is intended to prioritize inter-institutional as well as inter-disciplinary integration of all activities, including routine sharing of research findings across the major areas of population, clinical, and basic science.
项目摘要-MAE-WEST得分LAC 在生命过程中,慢性应激源会导致多器官衰老和功能障碍,最终导致 临床疾病的发展。性别仍然是衰老的性质和速度的关键决定因素,并最终 长寿。在哺乳动物物种中,更明显的是,女性的年龄与 男性。随着人类年龄的增加,女性和男性在生物衰老方面的差异 变得更加明显,最终导致女性占主导地位的一些重要病态 疾病状况,包括阿尔茨海默病和相关痴呆症(ADRD),心力衰竭和 保留射血分数(HFpEF)、进展性慢性肾脏疾病(CKD),进而导致全身虚弱。 这些重大疾病以女性为主的机制仍不清楚,也不是 可以用性激素的变化或生存偏见来解释。我们的初步工作支持一个中心假设 炎症性二十烷基类介质的性别二型性导致微血管中的性别差异 功能障碍,进而与年龄相关多器官疾病的性别差异有关,包括ADRD、HFpEF和 CKD。ADRD、HFpEF和CKD女性占优势的共同病理生理学基础 这是有效干预措施的关键,可减轻妇女因年龄引起的疾病的过重负担。 激发了我们的发现,并迫切需要了解性别差异的决定因素和驱动因素 对于与年龄相关的重大疾病结局,我们建议建立微血管老化和二十碳联体- 女性对系统性衰老韧性的评价(Mae-West)(“活到老,活不老!”) 性别差异专业研究卓越中心(SCORE),回应NIH RFA-OD-19-013。 我们的目标是形成一个稳健和可持续的学术活动结构,以系统地 探讨二十烷类化合物与微血管功能障碍和年龄相关性的性别差异 终末器官疾病,最初的重点是微血管老化对大脑、心脏和肾脏功能的影响。 这一目标将通过一个出色的临床医生-科学家合作团队(具有老年病学专业知识, 心脏病和肾脏病)、流行病学家、基础科学家和转化学家、分析化学家、 生物统计学家和生物信息学家。利用我们的集体经验、资源和基础设施,我们 将通过三个基础项目推进科学事业,这些项目是一致的和互补的 独立自主。为了充分发挥这一雄心勃勃的科学和教育议程的潜力,我们建立了 领导管理核心,用于监督运营、受托责任和提高效率。在……里面 建立MAE-West得分,我们将在现有协作的基础上扩展并使组织正规化 旨在优先考虑跨机构和跨学科的科学和指导领导力 整合所有活动,包括在主要人口领域例行分享研究成果, 临床和基础科学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cathleen Noel Bairey Merz其他文献

Cathleen Noel Bairey Merz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cathleen Noel Bairey Merz', 18)}}的其他基金

MAE-WEST SCORE Project 2 Clinical
MAE-WEST SCORE 项目 2 临床
  • 批准号:
    10450762
  • 财政年份:
    2020
  • 资助金额:
    $ 22.81万
  • 项目类别:
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
  • 批准号:
    10198755
  • 财政年份:
    2020
  • 资助金额:
    $ 22.81万
  • 项目类别:
MAE-WEST SCORE Career Enhance Core
MAE-WEST SCORE 职业提升核心
  • 批准号:
    10450757
  • 财政年份:
    2020
  • 资助金额:
    $ 22.81万
  • 项目类别:
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
  • 批准号:
    10450755
  • 财政年份:
    2020
  • 资助金额:
    $ 22.81万
  • 项目类别:
MAE-WEST SCORE Career Enhance Core
MAE-WEST SCORE 职业提升核心
  • 批准号:
    10198757
  • 财政年份:
    2020
  • 资助金额:
    $ 22.81万
  • 项目类别:
MAE-WEST SCORE Project 2 Clinical
MAE-WEST SCORE 项目 2 临床
  • 批准号:
    10198761
  • 财政年份:
    2020
  • 资助金额:
    $ 22.81万
  • 项目类别:
MAE-WEST SCORE Leadership Administrative Core
MAE-WEST SCORE 领导力行政核心
  • 批准号:
    10198756
  • 财政年份:
    2020
  • 资助金额:
    $ 22.81万
  • 项目类别:
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
  • 批准号:
    10817498
  • 财政年份:
    2020
  • 资助金额:
    $ 22.81万
  • 项目类别:
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
女性缺血综合征评估 (WISE) - 冠状动脉微血管功能障碍导致射血分数保留 (HFpEF) 的先兆心力衰竭的机制
  • 批准号:
    9922714
  • 财政年份:
    2019
  • 资助金额:
    $ 22.81万
  • 项目类别:
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
女性缺血综合征评估 (WISE) - 冠状动脉微血管功能障碍导致射血分数保留 (HFpEF) 的先兆心力衰竭的机制
  • 批准号:
    10576287
  • 财政年份:
    2019
  • 资助金额:
    $ 22.81万
  • 项目类别:

相似海外基金

Data Resource and Administrative Coordination Center for the Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes Consortium
精神科和神经发育障碍风险基因联盟的可扩展和系统神经生物学数据资源和行政协调中心
  • 批准号:
    10642251
  • 财政年份:
    2023
  • 资助金额:
    $ 22.81万
  • 项目类别:
Administrative/Coordination Core
行政/协调核心
  • 批准号:
    10250341
  • 财政年份:
    2017
  • 资助金额:
    $ 22.81万
  • 项目类别:
Administrative/Coordination Core
行政/协调核心
  • 批准号:
    9205190
  • 财政年份:
    2017
  • 资助金额:
    $ 22.81万
  • 项目类别:
PGRN Administrative Coordination Hub, ACH (PGRN)
PGRN 行政协调中心,ACH (PGRN)
  • 批准号:
    9302796
  • 财政年份:
    2015
  • 资助金额:
    $ 22.81万
  • 项目类别:
Scientific and Administrative Coordination Core
科学和行政协调核心
  • 批准号:
    8880258
  • 财政年份:
    2015
  • 资助金额:
    $ 22.81万
  • 项目类别:
PGRN Administrative Coordination Hub, ACH (PGRN)
PGRN 行政协调中心,ACH (PGRN)
  • 批准号:
    8946851
  • 财政年份:
    2015
  • 资助金额:
    $ 22.81万
  • 项目类别:
Scientific Leadership and Administrative Coordination of PPG
PPG的科学领导和行政协调
  • 批准号:
    8583041
  • 财政年份:
    2013
  • 资助金额:
    $ 22.81万
  • 项目类别:
Scientific and Administrative Coordination Core (SAC CORE)
科学和行政协调核心(SAC CORE)
  • 批准号:
    8092703
  • 财政年份:
    2010
  • 资助金额:
    $ 22.81万
  • 项目类别:
Scientific and Administrative Coordination Core (SAC CORE)
科学和行政协调核心(SAC CORE)
  • 批准号:
    7751737
  • 财政年份:
    2009
  • 资助金额:
    $ 22.81万
  • 项目类别:
Administrative & Coordination
行政的
  • 批准号:
    7513831
  • 财政年份:
    2007
  • 资助金额:
    $ 22.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了